Loading data for TCMD — first visit, this takes a few seconds.
Tactile Systems Technology, Inc.
22.51 -0.06 (-0.27%)
- Capitalización de mercado
- $509.9M
- Volumen
- 191K
- Próxima fecha de resultados
- May 4, 2026
Tactile Systems Technology, Inc. (TCMD): cotización, análisis y datos
Valor intrínseco
Pronóstico del analista
Previsiones bursátiles →Últimos resultados
| Reportado | Vs. estimación | Cambio interanual | |
|---|---|---|---|
| Ingresos | $85.70M | n/a | +8.61% |
| EPS | $0.36 | +$0.19 | +427.27% |
Métricas
- Precio de compra
- 21.66
- Ingresos (TTM)
- 350M
- Beneficio neto (TTM)
- 24.9M
- 0.79
- 1.07
- 21.04
- 15.47
- P/B (TTM)
- 2.28
- P/S (TTM)
- 1.46
- Fecha de resultados
- May 4, 2026
- Precio de venta
- 38.01
- Volumen
- 191,038
- Volumen medio (20D)
- 300,620
- Abierto
- 22.48
- Anterior Cerrar
- 22.57
- Rango del día
- 22.25 - 22.63
- Rango de 52 semanas
- 13.38 - 37.77
- analista
- n/a
- Precio objetivo
- n/a
- Dividendos
- n/a
- Fecha ex dividendo
- n/a
Acerca de Tactile Systems Technology, Inc.
Ver perfil →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Industria Medical Devices
Sector Healthcare
IPO Fecha Jul 28, 2016
Empleados 1,086
Bolsa de Valores NasdaqGM
Símbolo bursátil TCMD
Sitio web https://tactilemedical.com